Farid Rashidi

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost et al. · JAMA · 2021 · 653 citations · Full text

Pharmacy, Pharmacotherapy, Critical Care Pharmacology +16

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis Research · 2020 · 84 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 79 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study

Farid Rashidi, Stefano Barco, Farin Kamangar et al. · Thrombosis Research · 2020 · 73 citations · Full text

Medicine, Hematology, Infectious Diseases +11

Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease

Shaghayegh Rahimirad, Mohammad Reza Ghaffary, Mohammad Hossein Rahimi-Rad et al. · Tuberkuloz ve Toraks · 2017 · 40 citations · Full text

Medicine, Hematology, Internal Medicine +10